|
Compressive Strength
|
D019245 |
[The maximum compression a material can withstand without failure. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed, p427)
] |
|
Serotonin Syndrome
|
D020230 |
[An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.
] |
|
Corticoviridae
|
D019240 |
[The sole species in the genus Corticovirus, family CORTICOVIRIDAE.
, A family of icosahedral, lipid-containing, non-enveloped bacteriophages containing one genus (Corticovirus).
] |
|
Child Nutrition Disorders
|
C18.654.180 |
|
|
Fuselloviridae
|
D019241 |
[Species in the genus Fusellovirus.
, A family of lemon-shaped DNA viruses infecting ARCHAEA.
, Genus in the family FUSELLOVIRIDAE.
] |
|
Receptor Cross-Talk
|
D020239 |
[The simultaneous or sequential binding of multiple cell surface receptors to different ligands resulting in coordinated stimulation or suppression of signal transduction.
] |
|
Fictional Works as Topic
|
L01.178.682.192.459 |
|
|
Miliaria
|
C17.800.946.492 |
|
|
Alexia, Pure
|
D020237 |
[Loss of the power to comprehend written materials despite preservation of the ability to write (i.e., alexia without agraphia). This condition is generally attributed to lesions that "disconnect" the visual cortex of the non-dominant hemisphere from language centers in the dominant hemisphere. This may occur when a dominant visual cortex injury is combined with underlying white matter lesions that involve crossing fibers from the occipital lobe of the opposite hemisphere. (From Adams et al., Principles of Neurology, 6th ed, p483)
] |
|
LEOPARD Syndrome
|
C17.800.621.430.530.550.525 |
|
|
Prosopagnosia
|
D020238 |
[The inability to recognize a familiar face or to learn to recognize new faces. This visual agnosia is most often associated with lesions involving the junctional regions between the temporal and occipital lobes. The majority of cases are associated with bilateral lesions, however unilateral damage to the right occipito-temporal cortex has also been associated with this condition. (From Cortex 1995 Jun;31(2):317-29)
] |
|
Gait Apraxia
|
D020235 |
[Impaired ambulation not attributed to sensory impairment or motor weakness. FRONTAL LOBE disorders; BASAL GANGLIA DISEASES (e.g., PARKINSONIAN DISORDERS); DEMENTIA, MULTI-INFARCT; ALZHEIMER DISEASE; and other conditions may be associated with gait apraxia.
] |
|
Amnesia, Transient Global
|
D020236 |
[A syndrome characterized by a transient loss of the ability to form new memories. It primarily occurs in middle aged or elderly individuals, and episodes may last from minutes to hours. During the period of amnesia, immediate and recent memory abilities are impaired, but the level of consciousness and ability to perform other intellectual tasks are preserved. The condition is related to bilateral dysfunction of the medial portions of each TEMPORAL LOBE. Complete recovery normally occurs, and recurrences are unusual. (From Adams et al., Principles of Neurology, 6th ed, pp429-30)
] |
|
Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome
|
C08.381.495.389.250 |
|
|
Gait Disorders, Neurologic
|
D020233 |
[Gait abnormalities that are a manifestation of nervous system dysfunction. These conditions may be caused by a wide variety of disorders which affect motor control, sensory feedback, and muscle strength including: CENTRAL NERVOUS SYSTEM DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; or MUSCULAR DISEASES.
] |
|
Leukotriene C4
|
D23.469.050.175.450.725.400 |
|
|
Gait Ataxia
|
D020234 |
[Impairment of the ability to coordinate the movements required for normal ambulation (WALKING) which may result from impairments of motor function or sensory feedback. This condition may be associated with BRAIN DISEASES (including CEREBELLAR DISEASES and BASAL GANGLIA DISEASES); SPINAL CORD DISEASES; or PERIPHERAL NERVOUS SYSTEM DISEASES.
] |
|
Oxypurinol
|
D03.383.742.550 |
|
|
Daunorubicin
|
D02.455.426.559.847.562.050.200 |
|
|
Practice Patterns, Dentists'
|
D019239 |
[Patterns of practice in dentistry related to diagnosis and treatment.
] |
